Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine
Dr. Vito Di Marco, Alfredo Marzano, Pietro Lampertico, Pietro Andreone, Teresa Santantonio, Piero Luigi Almasio, Mario Rizzetto, Antonio Craxì – 7 March 2007 – The effect of lamivudine treatment on the outcome of patients with hepatitis B e antigen (HBeAg)‐negative chronic hepatitis is unclear. In a retrospective multicenter study, we have analyzed the virological events observed during lamivudine therapy in patients with HBeAg‐negative chronic hepatitis and evaluated the correlation between virological response and clinical outcomes.